Abstract:The addition of the methyl-7-guanosine (m7G) "cap" on the 5' ends of coding and some non-coding RNAs is essential for their protein coding capacity and biochemical activity, respectively. It was previously considered that capping was a constitutive process that generates a complete cap on all transcripts at steady-state. However, development of new methodologies demonstrated that steady-state capping is a dynamic and regulatable feature of many coding and non-coding RNAs. Indeed, capping status of specific RNAs can flux during differentiation and development, thereby impacting on their protein-coding capacity and activity. Moreover, in some primary cancer specimens, capping can be elevated for transcripts encoding proteins involved in proliferation and survival corresponding to their increased protein levels. Overexpression of one of the capping enzymes (RNMT), the transcription factor MYC or the eukaryotic translation initiation factor eIF4E all led to increased levels of steady-state capping of selected transcripts. Additionally, transcripts can be decapped and recapped, allowing these to be sequestered until needed. This review provides a summary of the major advances in enzymatic and affinity-based approaches to quantify m7G capping. Further, we summarize the evidence for regulation of capping. Capping has emerged as a significant regulatory step in RNA metabolism which is poised to impact a myriad of biological processes.

CAPAM: The mRNA Cap Adenosine N6-Methyltransferase

Cap-specific terminal N 6-methylation of RNA by an RNA polymerase II-associated methyltransferase

Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAs

The cap-specific m6A methyltransferase, PCIF1/CAPAM, is dynamically recruited to the gene promoter in a transcription-dependent manner

CAPturAM, a Chemo-Enzymatic Strategy for Selective Enrichment and Detection of Physiological CAPAM-Targets

The Mammalian Cap-Specific m6Am RNA Methyltransferase PCIF1 Regulates Transcript Levels in Mouse Tissues

Cap-specific Terminal N6-methyladeonsine Methylation of RNA Mediated by PCIF1 and Possible Therapeutic Implications

N1-methyladenosine Formation, Gene Regulation, Biological Functions, and Clinical Relevance

The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells

Cap-Specific m6Am Methyltransferase PCIF1/CAPAM Regulates mRNA Stability of RAB23 and CNOT6 through the m6A Methyltransferase Activity

To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity

Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome

Structural and Functional Insights into Eukaryotic Mrna Decapping

Structural and Functional Control of the Eukaryotic Mrna Decapping Machinery

PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression

PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine

The cap epitranscriptome: Early directions to a complex life as mRNA

Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase

Stabilized 5' Cap Analogue for Optochemical Activation of mRNA Translation

Trinucleotide mRNA Cap Analogue N 6-Benzylated at the Site of Posttranscriptional m6 A m Mark Facilitates mRNA Purification and Confers Superior Translational Properties In Vitro and In Vivo

The mechanism of mRNA cap recognition